Data, Peptides, and AI: 2026 Quarter 2 Pharmacy Update with Dr. Nicolette Mathey, PharmD, Dotti CRM

Send us Fan MailSend us Fan MailSchedule an Rx AssessmentWhat's really going on with peptides, AI, and the future of independent pharmacy? Turns out, quite a lot.Dr. Nicolette Mathey, PharmD, Founder and CEO of Atrium24 and Dotti CRM, for her quarterly update on the independent pharmacy landscape.We talk about:Headwinds and tailwinds for Q2 of independent pharmacyUpcoming PCAC meeting and what it means for peptide compoundingThe dangerous peptide gray marketHow AI is eliminating inefficiencies and transforming pharmacy salesAnd more!Stay connected with Nicolette, Atrium24, and Dotti: Nicolette’s LinkedInAtrium24 WebsiteAtrium24 FacebookAtrium24 LinkedInStay connected with us: FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterBonnie Bond – CPA LinkedInBonnie Bond – CPA Twitter More resources on this topic: Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24Podcast – A Pharmacists Run for Congress with Dr. Didi Okpareke, PharmD, RPhPodcast – KPIs for the Rapid Growth Pharmacy with Jim Hrncir, R. Ph, Owner of Las Colinas Compounding Pharmacy